upper abdominal pain nausea vomiting
Posted by admin on 10 July, 2011
No comments yet
This item was filled under [ Most Popular ]
Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint of Reducing SEGA Tumor Size in Patients With Tuberous …
EAST HANOVER, N.J., July 8, 2011 /PRNewswire/ — Novartis Pharmaceuticals Corporation (“Novartis”) announced today Phase III trial results that showed more than one-third of patients taking Afinitor® (everolimus) tablets* experienced a 50% or greater reduction in the size of their subependymal giant cell astrocytomas (SEGAs), non-cancerous brain tumors associated with tuberous sclerosis complex …
